Page last updated: 2024-12-05

piperonyl alcohol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

piperonyl alcohol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10322
CHEBI ID167431
SCHEMBL ID49914
MeSH IDM0123332

Synonyms (66)

Synonym
einecs 207-808-4
benzyl alcohol, 3,4-(methylenedioxy)-
unii-4163k563gs
4163k563gs ,
hsdb 8494
heliotropyl alcohol
nsc 26265
ai3-05702
CHEBI:167431
1,3-benzodioxol-5-yl-methanol
nsc26265
nsc-26265
benzyl alcohol,4-(methylenedioxy)-
piperonol
piperonyl alcohol
1-hydroxymethyl-3,4-methylenedioxybenzene
1,3-benzodioxole-5-methanol
3,4-methylenedioxybenzyl alcohol
495-76-1
5-hydroxymethyl-1,3-benzodioxole
SDCCGMLS-0065920.P001
benzo[1,3]dioxol-5-ylmethanol
DALC2-H_000040
1,3-benzodioxol-5-ylmethanol
AP-065/40214405
inchi=1/c8h8o3/c9-4-6-1-2-7-8(3-6)11-5-10-7/h1-3,9h,4-5h
piperonyl alcohol, 98%
STK397489
P0457
helioalcohol
(1,3-benzodioxol-5-yl)methanol
AKOS000119342
BBL011934
AM803952
benzo[d][1,3]dioxol-5-ylmethanol
FT-0614397
3,4-(methylenedioxy)benzenemethanol
benzo(1,3)dioxol-5-ylmethanol
3,4-methylenedioxyphenylmethanol
(benzodioxol-5-yl)methanol
SCHEMBL49914
(2h-1,3-benzodioxol-5-yl)methanol
FS-1186
3,4 -methylendioxy-benzylalcohol
3,4-methylenedioxyphenyl methanol
3,4-(methylenedioxy)-benzyl alcohol
3,4-(methylenedioxy)benzyl alcohol
benzo[1,3]dioxol-5-yl-methanol
3,4-(methylenedioxy)phenylmethanol
benz[1,3]dioxol-5-yl-methanol
3,4-methylendioxy-benzylalcohol
3,4-methylendioxybenzylalcohol
3,4-methylenedioxy-benzyl alcohol
3,4-methylenedioxy benzyl alcohol
DTXSID3060089
piperonylalkohol
F0001-1287
mfcd00005836
piperonylalcohol
SY033132
1,3-benzodioxol-5-ylmethanol; helioalcohol
(1,3-dioxaindan-5-yl)methanol
EN300-20232
5-(hydroxymethyl)-1,3-benzodioxole
Q27258401
Z104477372

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" With worker ants the toxic effects started with compound 5 and increased with the number of carbons in the side chain."( Toxicity of synthetic piperonyl compounds to leaf-cutting ants and their symbiotic fungus.
Bacci Júnior, M; Bueno, FC; Bueno, OC; Correa, AG; Crisóstomo, FR; da Silva, MF; Fernandes, JB; Hebling, MJ; Pagnocca, FC; Victor, SR; Vieira, PC, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzodioxoles
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.43 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.46 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]